| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |